SCHEMBL17479537

SCHEMBL17479537

O=C1N(c2ccccc2)C(=O)C12C[C@H]1C=C[C@@H]2C1

nearest known ligand 0.46

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ELANE P08246 5/20 0.40
POLB P06746 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ALDH1A1 P00352 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
FPR1 P21462 1/20 0.36
MGLL Q99685 1/20 0.35
ATM Q13315 1/20 0.35
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7921355 1.00 ELANE (0.40) ELANEPOLBMEN1KMT2AALDH1A1
SCHEMBL13025196 0.77 ALDH1A1 (0.35) ELANEPOLBMEN1KMT2AALDH1A1
SCHEMBL16034793 0.75
SCHEMBL5322625 0.75 ALDH1A1 (0.33) ALDH1A1
SCHEMBL9705137 0.75 CYP2D6 (0.37)
SCHEMBL11740261 0.74 MAOB (0.36)
SCHEMBL18107021 0.69 CYP2D6 (0.33)
SCHEMBL17503523 0.69 CYP2D6 (0.36)
SCHEMBL6254118 0.67 CYP2D6 (0.35)
SCHEMBL1739099 0.67 KDM1A (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210301078-A1 COMPOSITIONS AND METHODS OF MAKING POLYMERIZING NUCLEIC ACIDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-09-30 US disclosed
US-11072681-B2 Compositions and methods of making polymerizing nucleic acids THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-07-27 US disclosed
US-20170327633-A1 COMPOSITIONS AND METHODS OF MAKING POLYMERIZING NUCLEIC ACIDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2017-11-16 US disclosed
WO-2016018917-A2 COMPOSITIONS AND METHODS OF MAKING POLYMERIZED NUCLEIC ACIDS THE REGENTS OF THE UNIVERSITY OF CALIFORIA (US) 2016-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11072681-B2 Compositions and methods of making polymerizing nucleic acids RNGTT, NSUN2, POLN ELANE 2296/4885POLB 9/4885MEN1 1524/4885
US-20170327633-A1 COMPOSITIONS AND METHODS OF MAKING POLYMERIZING NUCLEIC ACIDS RNGTT, NSUN2, POLN ELANE 2296/4885POLB 9/4885MEN1 1524/4885
US-20210301078-A1 COMPOSITIONS AND METHODS OF MAKING POLYMERIZING NUCLEIC ACIDS RNGTT, NSUN2, POLN ELANE 2296/4885POLB 9/4885MEN1 1524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.